MML Investors Services
BBC icon

MML Investors Services’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

MML Investors Services’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,935
Closed -$576K – 3010
2025
Q4 		$576K Buy
+14,935
New +$507K ﹤0.01% 2161

Other funds holding BBC

KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $454M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
APW
Aurora Private Wealth Rockaway, New Jersey $140M AUM
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MML Investors Services's BBC Position: Q1 2026 in Review

MML Investors Services sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q1 2026, closing a stake of 14,935 shares — an estimated $576K sold.

MML Investors Services first reported a position in BBC in Q4 2025 and held it in 1 quarter. The position peaked at $576K in Q4 2025. 20 funds tracked by Wall St. Rank hold BBC as of Q1 2026.

  • MML Investors Services reported no remaining Virtus Biotech Clinical Trials ETF position as of Q1 2026 after selling out during the quarter.
  • MML Investors Services sold 14,935 Virtus Biotech Clinical Trials ETF shares in Q1 2026, an estimated $576K.
  • MML Investors Services first reported a position in Virtus Biotech Clinical Trials ETF in Q4 2025 and held it in 1 quarter.
  • MML Investors Services's Virtus Biotech Clinical Trials ETF position peaked at $576K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q1 2026.

Based on MML Investors Services's 13F filing for Q1 2026, filed 4 May 2026.